Johnson & Johnson (JNJ) is poised for a move up out of this consolidation, triangle formation. Upside potential 10% or so, based on the last two rallies. Downside risk to $61 or 4%.
Comments
olegm2
⋅
nice just reviewing this today, so far this is still working,
olegm2
⋅
bought a little @ 64 too on 4/20, i wont be surprised if it did touch 70.00. Now just waiting to see what happens.
timwest
⋅
It is time to re-view JNJ... it has been lagging the rallies in other drug stocks like ABT. I believe investors are stepping up to the plate now for shares of JNJ with today's breakout. March 30, 2012 10:27AM EST